Viewing Study NCT00402532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-01-01 @ 6:45 AM
Study NCT ID: NCT00402532
Status: COMPLETED
Last Update Posted: 2011-12-08
First Post: 2006-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Sponsor: Hannover Medical School
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung Transplantation View
None Immunosuppression View
None Mortality View
None Graft rejection View
None Bronchiolitis obliterans View
None Opportunistic infections View
None Nephrotoxicity View